Apolipoprotein E: From lipid transport to neurobiology

被引:245
作者
Hauser, Paul S. [1 ,2 ]
Narayanaswami, Vasanthy [1 ,3 ]
Ryan, Robert O. [1 ,2 ]
机构
[1] Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, Oakland, CA 94609 USA
[2] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA
[3] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA
基金
美国国家卫生研究院;
关键词
Apolipoprotein E; Cholesterol; Cardiovascular disease; Neurobiology; Alzheimer's disease; DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID-BETA-PEPTIDE; CENTRAL-NERVOUS-SYSTEM; E-DEFICIENT MICE; SPORADIC ALZHEIMERS-DISEASE; N-TERMINAL DOMAIN; BLOOD-BRAIN-BARRIER; E KNOCKOUT MICE; DIET-INDUCED HYPERCHOLESTEROLEMIA; CYSTEINE-ARGININE INTERCHANGE;
D O I
10.1016/j.plipres.2010.09.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein (apo) E has a storied history as a lipid transport protein. The integral association between cholesterol homeostasis and lipoprotein clearance from circulation are intimately related to apoE's function as a ligand for cell-surface receptors of the low-density lipoprotein receptor family. The receptor binding properties of apoE are strongly influenced by isoform specific amino acid differences as well as the lipidation state of the protein. As understanding of apoE as a structural component of circulating plasma lipoproteins has evolved, exciting developments in neurobiology have revitalized interest in apoE. The strong and enduring correlation between the apoE4 isoform and age of onset and increased risk of Alzheimer's disease has catapulted apoE to the forefront of neurobiology. Using genetic tools generated for study of apoE lipoprotein metabolism, transgenic "knock-in" and gene-disrupted mice are now favored models for study of its role in a variety of neurodegenerative diseases. Key structural knowledge of apoE and isoform-specific differences is driving research activity designed to elucidate how a single amino acid change can manifest such profoundly significant pathological consequences. This review describes apoE through a lens of structure-based knowledge that leads to hypotheses that attempt to explain the functions of apoE and isoform-specific effects relating to disease mechanism. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:62 / 74
页数:13
相关论文
共 250 条
[1]  
AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249
[2]   Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse [J].
Anderson, R ;
Barnes, JC ;
Bliss, TVP ;
Cain, DP ;
Cambon, K ;
Davies, HA ;
Errington, ML ;
Fellows, LA ;
Gray, RA ;
Hoh, T ;
Stewart, M ;
Large, CH ;
Higgins, GA .
NEUROSCIENCE, 1998, 85 (01) :93-110
[3]   Absence of central cholinergic deficits in ApoE knockout mice [J].
Anderson, R ;
Higgins, GA .
PSYCHOPHARMACOLOGY, 1997, 132 (02) :135-144
[4]   Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction [J].
Aoki, K ;
Uchihara, T ;
Sanjo, N ;
Nakamura, A ;
Ikeda, K ;
Tsuchiya, K ;
Wakayama, Y .
STROKE, 2003, 34 (04) :875-880
[5]   Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies [J].
Auld, DS ;
Kornecook, TJ ;
Bastianetto, S ;
Quirion, R .
PROGRESS IN NEUROBIOLOGY, 2002, 68 (03) :209-245
[6]   Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [J].
Bales, KR ;
Verina, T ;
Dodel, RC ;
Du, YS ;
Altstiel, L ;
Bender, M ;
Hyslop, P ;
Johnstone, EM ;
Little, SP ;
Cummins, DJ ;
Piccardo, P ;
Ghetti, B ;
Paul, SM .
NATURE GENETICS, 1997, 17 (03) :263-264
[7]   The LDL receptor: how acid pulls the trigger [J].
Beglova, N ;
Blacklow, SC .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (06) :309-317
[8]   Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system [J].
Bell, Robert D. ;
Sagare, Abhay P. ;
Friedman, Alan E. ;
Bedi, Gurrinder S. ;
Holtzman, David M. ;
Deane, Rashid ;
Zlokovic, Berislav V. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (05) :909-918
[9]   MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE [J].
BELLOSTA, S ;
MAHLEY, RW ;
SANAN, DA ;
MURATA, J ;
NEWLAND, DL ;
TAYLOR, JM ;
PITAS, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2170-2179
[10]  
BERSOT TP, 1976, J BIOL CHEM, V251, P2395